Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
so to clarify, you don't do any business with Titan and therefore hold no shares in Titan - or if you hold shares, you are doing business with Titan.
Looks like it provides insight and guidance on how to navigate the FDA process. Only those individuals who are considered experts in their field are asked to be speakers for companies looking to navigate the FDA process. James Shore, Titan's VP of Quality and Compliance is speaking on behalf of FDA regulations.
why?
FDA Sponsored event:
http://www.fdanews.com/mdsupplierqualitymanagementSpeaker
Just saying so u can all do ur due diligence rather than start shorting a stock bc someone "suggests" it.
You know how someone's email is made up: when it reads "ADMIN@thatpersonsname.com"
I'm not titan mgmt, my name is Mike Ockinyu.
He said he talked to a guy named posilock and even though he called him a c....sucker over the phone a couple of weeks ago that he felt compelled and moved to provide info to him
Randall said he never spoke to someone named Anthony from Jersey
This looks familiar, is this the change to the Titan foot pedals?
http://www.davidmoore-design.com/#intro-1
Plenty of law firms that specialize in this type of litigation, I think one you should consider is: Watson, Herbusch, Tal, E.Wacker
I have heard from Isrg rep, Neil Anblomi who said they don't see Titan as a threat.
That's fine and if he's not available, maybe Harry Balzac
Or...
#T.i.T.FX
TITAN Investors Together! #T.i.T
You mean dr Hargrove.
http://events.roundtable.com/Event_Center/ODM02/ODM02_casestudies.html
Plexus/Ethicon case study
I think there is a reporter, Mike Hunt, at WSJ that covers medical devices - someone could reach out to him.
A lot of similarities b/t what he started at Ximedica for SPORT and what the software engineers are doing that VERB has been hiring for
Sr. Project Mgr at Plexus is connected with VP Marketing at Verb - Dave herrmans
Just an FYI, whoever sends it to WSJ - to avoid making yourself look like an idiot, you might want to change Dr. Hargrove to Mr. Hargrove in Paragraph 6.
I know that Verb doesn't have a manufacturing facility, so they aren't manufacturing one on their own. I thought Plexus was manufacturing the Verb Robot - lot of Plexus personnel linked to Verb Personnel.
I agree and it's what I used to think but the last month has allowed some doubt about the completion of the robot to creep in. I am waiting to see what the suppliers do upon completion of the offering. That will give me a lot of info I need to decide my next step.
I will agree on this one, it's all about getting the design freeze and having a product. The last month has me worried that they are having a problem with the robot. A completed, functioning robot is the only thing that matters.
ding, ding, ding...we have a winner
I agree but some stooges think that they are going alone - which is asinine to say the least.
anyone that thinks they are going it alone is a stooge
Titans partner is paying EVC Group
I understand that but it was stated by a poster that Ximedica would not release the info and I want to clarify that point rather than have people think that Ximedica will not pass along that info.
Pope drove TRXC into the ground
This is your quote:
"To sell it to a partner, lots of engineering questions will need to be answered IMO. If we don't have access to the engineering team, how do we answer these questions?"
Your indicating that the information is in the engineers heads and not documented and verified - if that were the case, whey would anyone hire Ximedica or any engineering company to develop something. I can't even believe that someone would think that the specs, design, development etc would not be documented - what would be submitted for regulatory approval? How would it be manufactured and mass produced? How would you set up infrastructure to service the product?
It's called specs. Do u think that once they have a proven process to build the unit that they keep it under lock and key?
No way they are going it alone, what indications from an organizational standpoint show they are going it alone? I see ZERO, they have absolutely no infrastructure, they have what 7-8 employees. If you are holding stock and banking on them going alone, you might as well sell it all b/c this will go down to 10 cents if they go it alone- They will need to raise over $250M if they go it alone (minimum)
or the constant tinkering he wanted to do which delayed the process and increased expenses. IMO, him leaving will accelerate the process.
agree that all warrants thru April 2017 will expire before they can be excercised.
Thanks Captain Obvious. I will restate my position, I have never thought that they were going alone (if I do, I would not have invested), I've always thought it was a partnership/buyout - that is why we need the finished product.
Just decades in the medical device/healthcare space, understanding in-house development and outsourced development (pro's and con's of both) - familiar with regulatory process. I wouldn't be the least bit surprised if there is an announcement soon regarding CE. IMO - Fowler left to go back to his Better Moustrap consulting b/c the development and design of SPORT are done. FYI, Fowler started his Better Mousetrap company over 7 years ago which tells me he was a consultant for Titan and then was brought on in a fulltime role to complete development/design (probably a two year contract) - that is done and he moved back to being a fulltime consultant.
I'm not a mm so not interested in trading in/out of the stock (as you suggest). Obviously continuing to post on here to make one feel better is certainly a route that works for you.
I just don't agree with your assessment - my investment is based off a different assessment. Its not going to be 3-4 more years, the surgical robotics market is one of the fastest growing markets in healthcare. IMO, Titan and Ximedica are done with anymore tweaking of SPORT. Both are ready to move SPORT thru the regulatory process - starting with CE mark.
A finished Surgical robotics platform is what I want - once that is confirmed, PPS will rise. Can't sell without the finished product (otherwise PPS is a house of cards - i.e. TRXC). Nothing else matters for my investment.
If there is a problem with the robot and they can't freeze the design then we are all screwed anyway.